Geron Corporation - Common Stock — 貸借対照表 (NASDAQ:GERN)

Financials

総資産 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M 負債合計 59.78 M99.62 M110.58 M146.13 M313.46 M344.67 M 純資産合計 210.95 M126.42 M80 M247.95 M280.32 M225.87 M 負債および純資産合計 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M 有利子負債合計 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M 純負債 24.04 M49.83 M51.16 M81.94 M165.37 M41.99 M

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation - Common Stock

ニュース

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

ジェロン、バークレイズ・ヘルスケア会議で戦略的成長と将来計画を発表

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

ジェロンがTD Cowenで語る戦略的成長と市場拡大

Geron at TD Cowen: Strategic Growth and Market Expansion

Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)

Geron Corporation (GERN) Q4 2025 Earnings Call Transcript

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates